Keyphrases
Myelodysplastic Syndrome
100%
Arsenic Trioxide
100%
Trisenox
100%
Acute Promyelocytic Leukemia
33%
High Risk
16%
Hematological Malignancies
16%
Potential Gains
16%
China
16%
Malignancy
16%
Angiogenesis
16%
Apoptosis Induction
16%
Therapeutic Potential
16%
Neovascularization
16%
Prognostic Score
16%
Therapeutic Challenges
16%
Ineffective Hematopoiesis
16%
Toxicity Profile
16%
Biological Targets
16%
Leukemia Transformation
16%
Biologic Features
16%
Preclinical Investigation
16%
Ongoing Trials
16%
Scientific Rationale
16%
Long History
16%
Footnotes
16%
Antineoplastic Agents
16%
Apoptotic Potential
16%
Modern Therapy
16%
Antileukemic Agents
16%
Medicine and Dentistry
Arsenic Trioxide
100%
Treatment of Myelodysplastic Syndrome
100%
Myelodysplastic Syndrome
57%
Acute Promyelocytic Leukemia
28%
Hematologic Malignancy
14%
Cancer
14%
Angiogenesis
14%
Programmed Cell Death
14%
Maturation
14%
Hematopoiesis
14%
Leukemia
14%
Biological Target
14%
Anticarcinogen
14%
Antileukemic Agent
14%
Diseases
14%
Pharmacology, Toxicology and Pharmaceutical Science
Myelodysplastic Syndrome
100%
Arsenite
100%
Arsenous Acid
100%
Promyelocytic Leukemia
28%
Hematologic Malignancy
14%
Leukemia
14%
Biological Target
14%
Anticarcinogen
14%
Antileukemic Agent
14%
Diseases
14%